Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward
This surpasses the number of approvals supported in 2020
_256_384.jpg)
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
Key takeaways of recent quarter & conference call highlights
In the final analysis of Phase 3 COVE study data, SPIKEVAX showed 93% efficacy, with the efficacy remaining durable through six months after the administration of the second dose
Nat-Lenalidomide, a generic alternative to Revlimid, expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to myelodysplastic syndromes (MDS)
Subscribe To Our Newsletter & Stay Updated
